Logo

Myasthenia Gravis Treatment Market Size, Share, and Growth Forecast, 2025 - 2032

Myasthenia Gravis Treatment Market by Drug Class (Immunosuppressants, Monoclonal Antibodies, Cholinesterase Inhibitors, Corticosteroids), Disease Type (Generalized Myasthenia Gravis, Ocular Myasthenia Gravis), End-User (Hospital, Online Pharmacies, Specialty Clinics), and Regional Analysis for 2025-2032

ID: PMRREP33757
Calendar

December 2025

184 Pages

Author : Abhijeet Surwase

Healthcare
  1. Executive Summary
    1. Global Myasthenia Gravis Treatment Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 – 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2024A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Disease Type
  5. Global Myasthenia Gravis Treatment Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 – 2032
    3. Global Myasthenia Gravis Treatment Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Drug Class, 2019 – 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
        1. Immunosuppressants
        2. Monoclonal Antibodies
        3. Cholinesterase Inhibitors
        4. Corticosteroids
      4. Market Attractiveness Analysis: Drug Class
    4. Global Myasthenia Gravis Treatment Market Outlook: Disease Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Disease Type, 2019 – 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
        1. Generalized Myasthenia Gravis
        2. Ocular Myasthenia Gravis
      4. Market Attractiveness Analysis: Disease Type
    5. Global Myasthenia Gravis Treatment Market Outlook: End-User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End-User, 2019 – 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025 – 2032
        1. Hospital
        2. Online Pharmacies
        3. Specialty Clinics
      4. Market Attractiveness Analysis: End-User
  6. Global Myasthenia Gravis Treatment Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 – 2024
    3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 – 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Myasthenia Gravis Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Disease Type
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Immunosuppressants
      2. Monoclonal Antibodies
      3. Cholinesterase Inhibitors
      4. Corticosteroids
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
      1. Generalized Myasthenia Gravis
      2. Ocular Myasthenia Gravis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
      1. Hospital
      2. Online Pharmacies
      3. Specialty Clinics
    7. Market Attractiveness Analysis
  8. Europe Myasthenia Gravis Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Disease Type
      4. End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Immunosuppressants
      2. Monoclonal Antibodies
      3. Cholinesterase Inhibitors
      4. Corticosteroids
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
      1. Generalized Myasthenia Gravis
      2. Ocular Myasthenia Gravis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
      1. Hospital
      2. Online Pharmacies
      3. Specialty Clinics
    7. Market Attractiveness Analysis
  9. East Asia Myasthenia Gravis Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Disease Type
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Immunosuppressants
      2. Monoclonal Antibodies
      3. Cholinesterase Inhibitors
      4. Corticosteroids
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
      1. Generalized Myasthenia Gravis
      2. Ocular Myasthenia Gravis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
      1. Hospital
      2. Online Pharmacies
      3. Specialty Clinics
    7. Market Attractiveness Analysis
  10. South Asia & Oceania Myasthenia Gravis Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Disease Type
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Immunosuppressants
      2. Monoclonal Antibodies
      3. Cholinesterase Inhibitors
      4. Corticosteroids
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
      1. Generalized Myasthenia Gravis
      2. Ocular Myasthenia Gravis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
      1. Hospital
      2. Online Pharmacies
      3. Specialty Clinics
    7. Market Attractiveness Analysis
  11. Latin America Myasthenia Gravis Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Disease Type
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Immunosuppressants
      2. Monoclonal Antibodies
      3. Cholinesterase Inhibitors
      4. Corticosteroids
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
      1. Generalized Myasthenia Gravis
      2. Ocular Myasthenia Gravis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
      1. Hospital
      2. Online Pharmacies
      3. Specialty Clinics
    7. Market Attractiveness Analysis
  12. Middle East & Africa Myasthenia Gravis Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Disease Type
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Immunosuppressants
      2. Monoclonal Antibodies
      3. Cholinesterase Inhibitors
      4. Corticosteroids
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
      1. Generalized Myasthenia Gravis
      2. Ocular Myasthenia Gravis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
      1. Hospital
      2. Online Pharmacies
      3. Specialty Clinics
    7. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. Alexion Pharmaceutical Inc.
        1. Overview
        2. Segments and Deployments
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Grifols SA
      3. Avadel Pharmaceutical
      4. Novartis
      5. Pfizer Inc
      6. AbbVie Inc
      7. F Hoffmann-La Roche AG
      8. GlaxoSmithKline Plc
      9. Bausch Health Companies Inc
      10. Shire Plc
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

 

 

 

 

 

 

 

 

 

 

Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500SIN : +65 6531 3894 98
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -